loading

Cellectar Biosciences Inc Azioni (CLRB) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Research and Development
25.18%
3.1586
2.5233 2.3898 3.4271 6.2092
Costs And Expenses
17.32%
5.6906
4.8507 6.0375 6.401 12.74
Operating Income/Loss
17.32%
-5.6906
-4.8507 -6.0375 -6.401 -12.74
Nonoperating Income/Loss
2.80%
0.3954
0.4068 0.5896 -0.203 10.46
Income/Loss From Continuing Operations Before Tax
7.19%
-4.5018
-4.8507 -5.4479 -6.604 -5.4826
Income/Loss From Continuing Operations After Tax
135.08%
1.5588
-4.4439 -5.4479 -6.604 -2.3554
Net Income/Loss
19.16%
-5.2952
-4.4439 -5.4479 -6.604 -2.3554
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
84.18%
0.5001
3.162 1.6088 46.08 1.772
Diluted Average Shares
84.18%
0.5001
3.162 1.6088 46.08 1.5983
Basic Earnings Per Share
62.41%
-0.53
-1.41 -3.39 -0.14 -0.01
Diluted Earnings Per Share
62.41%
-0.53
-1.41 -3.39 -0.14 -0.01
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):